AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
 - EconoTimes)
NEW ORLEANS, Oct. 13, 2017 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 24, 2017 to file lead plaintiff applications in a securities class action lawsuit against PetMed Express, Inc. (NASDAQ:PETS), if they purchased the Company’s securities between May 8, 2017, and August 23, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Florida.
What You May Do
If you purchased securities of PetMed Express and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit http://ksfcounsel.com/cases/nasdaq-pets/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 24, 2017.
About the Lawsuit
PetMed Express and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On August 23, 2017, it was revealed through a comprehensive report issued by Aurelius Value entitled “PetMed: Exploiting America’s Opioid Epidemic” that PetMed Express had targeted its products, painkillers especially addictive synthetic opiates, to opioid users through the aggressive use of Google ads and other online marketing services, potentially facilitating the abuse of opiates as “human crossover painkillers.”
On this news, the price of PetMed Express shares plummeted.
About Kahn Swick & Foti, LLC
KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
206 Covington St.
Madisonville, LA 70447
